Skip to content

Savara SVRA Loss on Debt Extinguishment

Loss on Debt Extinguishment at other companies

Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
-$2.76M
PVL
Palvella TherapeuticsPVLA
$0-100%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
-$3.51M
TG Therapeutics logo
TG TherapeuticsTGTX
-$9.15M
Mannkind logo
MannkindMNKD
-$917K

Other financials

Income statement

See full
Revenue-
Operating income-$39.0M-37.1%
Net income-$37.3M-40.0%
EPS (diluted)-$0.15-25.0%

Balance sheet

See full
Cash & equivalents$38.8M+98.4%
Total debt$30.1M+1.8%
Total equity$176.0M+19.1%
Total assets$221.6M+17.1%

Cash flow

See full
Operating cash flow-$33.0M-21.5%
CapEx$54.0K+1,700%
Free cash flow-$33.1M-21.7%

Valuation

See full
Market cap$1.19B+247%
Enterprise value$1.19B+235%
P/S4,648.7×

Profitability

See full
Operating margin-19,183.3%
Net margin-19,305.1%
FCF margin-15,518.7%

Returns & leverage

See full
Return on equity-80%+4.7pp
Debt / equity0.2×0.0×
Current ratio13.5×-1.4×

Where this comes from

Reported directly by Savara in its filing.

Tagged under the XBRL concept us-gaap:GainsLossesOnExtinguishmentOfDebt.

The official record: Savara’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Savara's loss on debt extinguishment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Savara's loss on debt extinguishment?
Savara (SVRA) reported loss on debt extinguishment of -$546K in Q1 2025.
What does loss on debt extinguishment mean?
Non-cash loss from retiring debt before maturity, added back in operating cash flow since the cash impact is in financing.